Pay in 4 interest-free payments of $51.25 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
DPP8 is a novel therapeutic target for multiple myeloma
Molecular Weight: 217
4-Dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8
Smiles: COC1=CN=C(NS(=O)(=O)C2C=CC(N)=CC=2)N=C1
DRF-1042 Size:10mg solid DPP8 is a novel therapeuticDRF 1042 is an orally active derivative of Camptothecin. DRF 1042 acts to inhibit DNA topoisomerase I. DRF 1042 shows good anticancer activity against a panel of human cancer cell lines including multi drug resistance (MDR) phenotype. Product information CAS Number: 200619 13 2 Molecular Weight: 408. 40 Formula: C22H20N2O6 Chemical Name: (19S) 19 ethyl 19 hydroxy 12 (2 hydroxyethoxy) 17 oxa 3, 13 diazapentacyclo[11. 8. 0. 0, . 0, . 0, ]henicosa 1(21),
US$ 84.95
US$ 282.50